I just came back from an advanced screening of Marvel Entertainments (NYSE: MVL) Incredible Hulk and it surpassed my expectations as did Iron Man before it.

The preview Wednesday night, two days ahead of the premier scheduled for Friday the 13th, is probably too scary for little tykes but it is a superb blend of movie technology magic and the passion of the cast and crew.

It's all in the eyes. Unlike the glib Tony Stark character in Iron Man, played fittingly by Robert Downey Jr., Edward Norton is the emotionally gamma ray charged green powerhouse that only roars, and must communicate his feeling though his eyes. This is the case when the Hulk's temper rages and when he is expressing his affection for Dr. Elizabeth Ross, played by to perfection by Liv Tyler.

While the movie trailers emphasize the Hulk as powerful colossus, Marvel has also managed to shape the behemoth into the endearing character of comic hero fame.

Once the action starts it does not let up much, and it's too loud for my middle age constitution. However, I think Marvel has another hit on its hands.

Marvel's stock closed at $36.33 on Wednesday afternoon. Prior to the opening of Iron Man it was around $29.00. A 20% return in a few weeks is great. I hope to review the current stock metrics in more detail soon and might buy some.

To buy it six weeks ago would have been a good short term investment but would have been speculative. I think that is still the case now. More so because of the stock appreciation near its all time high, but perhaps less so, given the track record and solid strategy they seem to have developed.

Sheldon Liber is the CEO of a small private investment company and the principal for design and research at an architecture & planning firm. He writes the columns Chasing Value and Serious Money. Disclosure: I do not own stock in MVL but I am considering it.